These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20873423)

  • 1. Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J
    Acta Pol Pharm; 2010; 67(5):537-42. PubMed ID: 20873423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J; Nowaczyk A; Kulig K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):13-25. PubMed ID: 20949258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
    Sapa J; Filipek B; Nowiński L
    Pharmacol Rep; 2011; 63(2):455-63. PubMed ID: 21602601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
    Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
    Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
    Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
    Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
    Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic properties of some aroxyethylamine derivatives with adrenolytic activity.
    Maciag D; Bednarski M; Filipek B; Pociecha T; Szkaradek N; Marona H
    Pharmazie; 2008 Jun; 63(6):480-4. PubMed ID: 18604994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.
    Dylag T; Zygmunt M; Maciag D; Handzlik J; Bednarski M; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2004 Dec; 39(12):1013-27. PubMed ID: 15571863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
    Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L
    Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
    Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
    Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.
    Abraham S; Beatch GN; MacLeod BA; Walker MJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1166-73. PubMed ID: 2557414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
    Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
    Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities.
    Kubacka M; Mogilski S; Filipek B; Marona H
    Eur J Pharmacol; 2013 Nov; 720(1-3):237-46. PubMed ID: 24161912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
    Rapacz A; Sapa J; Bednarski M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Sep; 738():14-21. PubMed ID: 24876055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
    Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers.
    Bednarski M; Otto M; Dudek M; Siwek A; Zygmunt M; Knutelska J; Nowiński L; Groszek G; Sapa J
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):81-7. PubMed ID: 26384857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.